For the complete report, get in touch with us at : info@netscribes.com Abstract: Netscribes’ latest market research report titled Nutraceuticals Market in India 2014 states that the increasing shift towards preventive medication, backed by the growing purchasing power of Indian consumers, is fueling growth in the market. The nutraceutical sector can be categorized into three broad segments – dietary supplements, functional food and functional beverages. Dietary supplements have witnessed a consistent rise in demand owing to the increasing health consciousness prevalent among individuals, particularly the growing Indian middle class population. Probiotics market is at a nascent stage. However, it is one of the most promising categories under the functional food segment and has huge growth potential in the near future, driven by the growing interests of consumers as well as market players. Modern day on-the-go lifestyles of Indian consumers have also promoted the growing use of functional beverages such as energy drinks and fortified juices. People today are becoming more prone to consuming immunity-enhancing food supplements and wellness related products. This is promoting the growth of the nutraceuticals market with players diversifying into production of various new categories of products. Ayurvedic nutraceuticals, cosmeceuticals and nanoceuticals are some of the emerging products in the market. Currently, there is a good mix of pharmaceutical and food companies present in the market. With time, consumers have emerged as being more conscious about their health and how they look and feel, thus providing tremendous growth prospects for the market, which players can capitalize upon. Table of Contents: Slide 1: Executive Summary Macroeconomic Indicators Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 – Dec 2013) Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 – Jul 2013), Exchange Rate: Half Yearly (Aug 2013 – Jan 2014) Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2009-10, 2010-11, 2011-12, 2012-13), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13) Introduction Slide 5: Nutraceutical – Definition and Segments Slide 6: Dietary Supplements – Overview Slide 7: Functional Foods – Overview Slide 8: Functional Beverages – Overview Slide 9: Genesis of Probiotics Slide 10: Therapeutic Benefits of Probiotics Slide 11: Pharmaceutical Company-wise Probiotics Brands Market Overview Slide 12: Nutraceuticals – Market Overview, Market Size & Growth (Value-Wise; FY2012 – FY2018e), Market Segmentation (Percentage Share; 2012) Slide 13: Probiotics – Market Overview, Market Size & Growth (Value-Wise; 2011 – 2018e), Market Segmentation (Percentage Share; 2012) Drivers & Challenges Slide 14: Drivers and Challenges – Summary Slide 15-19: Drivers Slide 20-21: Challenges

1. Nutraceuticals Market – India
April 2014

2. 2NUTRACEUTICALS MARKET IN INDIA 2014.PPT
Executive Summary
Market
Drivers &
Challenges
Trends
Competition
 Market valued at INR x bn in 2011-12 and is estimated to grow at a CAGR of y % over the next six years
 Comprises three segments, dietary supplements, functional foods and functional beverages
 India accounts for a mere z% of the total world market for nutraceuticals
Drivers:
– Faulty Lifestyles Leading to related Disorders
– Increasing Disposable Income
– Rise in Ageing Population
– Growing Awareness towards Preventive Care and Self
Medication
– Expanding Sales Channels
– Ideal Manufacturing Destination
Challenges:
– Lack of Standardization
– High Product Price
 Fortified foods
 Ayurvedic nutraceuticals
 Foreign tie-ups
 Initiatives by players to educate consumers
 Encapsulation
 Cosmeceuticals and Nanoceuticals
Probiotic
Market
 Probiotics in India generally comes in two forms : Drugs and Packaged foods and beverages
 Major pharmaceuticals companies have become active in this space and are devising newer drugs and products,
however current drugs are predominant in the area of gastroenterology
Amway India EnterprisesYakult DanoneRanbaxy LaboratoriesAbbott India
Herbalife International IndiaHimalaya DrugDr. Reddy's LaboratoriesDabur India
Major Private PlayersMajor Public Players

3. 3NUTRACEUTICALS MARKET IN INDIA 2014.PPT
•Macro Economic Indicators
•Introduction
•Market Overview
•Drivers & Challenges
•Value Chain Analysis
•Trends
•Government Regulations
•Competitive Landscape
•Strategic Recommendations
•Appendix

4. 4
SAMPLE
Economic Indicators (1/3)
GDP at Factor Cost: Quarterly
Inflation Rate: Monthly
-2
-1
0
1
2
Aug 20-- - Sep 20--
b2
Jul 20-- - Aug 20--
b1
%
Nov 20-- - Dec 20--
b5
Oct 20-- - Nov 20--
b4
Sep 20-- - Oct 20--
b3
11
12
13
14
15
a14
Q1
a1
a5
a9
a13
a7
a11
Q2
a2
a6
a10
INR tn
Q4
a4
a8
a12
Q3
a3
2013-14
2011-12
2012-13
2010-11
NUTRACEUTICALS MARKET IN INDIA 2014.PPT

5. 5NUTRACEUTICALS MARKET IN INDIA 2014.PPT
Nutraceutical – Definition and Segments
•The term Nutraceutical comes from the words “nutrition” combined with “pharmaceutical”, and implies a food or
food product that reportedly provides health and medical benefits, including the prevention and treatment of
diseases
•It comprises extracts of food having a medicinal impact on human health and comes in the form of food, dietary
supplements, and medical foods
Dietary Supplements Functional Foods Functional Beverage
•xx •yy • zz

6. 6NUTRACEUTICALS MARKET IN INDIA 2014.PPT
Increasing shift towards preventive therapies and increasing
disposable income has led to a growing market
• India accounts for only x% of the world nutraceuticals
market
• Nutraceuticals market in India is growing at a fast pace
and is expected to be almost y in size by 20--
• Growing consciousness among Indians about health and
how they look and feel is resulting in greater demand
for product 1, product 2 and product 3
 Product 2 segment is witnessing sizeable demand
 Product 4 will be a rapidly growing category until 20--
followed by dietary supplements
• Several pharmaceutical companies are entering this
space, realizing that nutraceutical products can act as a
supplementary product for their y products
 There is a rising penetration of pharmaceutical companies in
nutraceutical segment in the form of x1 and x2 supplements
• There are more Indian players than multinationals in
the market as it is a relatively low technology section
compared to pharmaceuticals
• Product 6 is one of the most emerging and nascent
segments in this market with increasing consumer
acceptance and greater player attention expected to
drive its growth
Nutraceuticals – Market Overview Market Size and Growth
0
100
200
300
400
INR bn
20--e
+x% a6
20--e
a5
a3
20--e20--
a7
a1
20--e
a4
a2
20-- 20--e
Market Segmentation (20--)
x2%
x1%
x3%
Segment 3Segment 2Segment 1

7. 7NUTRACEUTICALS MARKET IN INDIA 2014.PPT
Drivers & Challenges – Summary
Drivers
Faulty Lifestyles Leading to related
Disorders
Increasing Disposable Income
Rise in Ageing Population
Growing Awareness towards
Preventive Care and Self Medication
Expanding Sales Channels
Ideal Manufacturing Destination
Challenges
Lack of Standardisation
High Product Price

8. 8NUTRACEUTICALS MARKET IN INDIA 2014.PPT
Faulty Lifestyles Leading to Related Disorders Impact
• xx
Prevalence of Chronic Lifestyle Diseases in India
0
50
100
150
200
250
300
x4
x7
Hypertension
x6
Cardiovascular
Diseases
mn
x5
x2 x8
x3
x1
Diabetes Cancer
20-- 20--e
Rise in chronic diseases is encouraging people to move
towards preventive treatment

9. 9NUTRACEUTICALS MARKET IN INDIA 2014.PPT
Nutraceuticals Market – Value Chain
X1
X7
X4
X2
X5
X6
X3

10. 10
SAMPLE
NUTRACEUTICALS MARKET IN INDIA 2014.PPT
Trends – Summary
`
Fortified Foods
Ayurvedic Nutraceuticals
Cosmeceuticals and Nanoceuticals
Encapsulation
Trends
Foreign Tie-ups
Players Educating Consumers

11. 11NUTRACEUTICALS MARKET IN INDIA 2014.PPT
Fortified foods are emerging as the new growth segment for
the nutraceuticals industry
•yy
Advantages
•xx
Fortified Foods
•zz
Examples

12. 12NUTRACEUTICALS MARKET IN INDIA 2014.PPT
Genesis of Food Safety and Standards Act, 20--
• xx • yy • zz
Pre 20-- 20-- -20-- Post 20--
Conclusion

13. 13
SAMPLE
NUTRACEUTICALS MARKET IN INDIA 2014.PPT
Market Competition – Porter’s Five Forces Analysis
Bargaining Power of Suppliers
Threat of New Entrants
Competitive Rivalry Bargaining Power of Buyers
Threat of Substitutes
Impact
Low
Impact
Low
Impact
LowImpact
Medium
Impact
Medium

14. 14
Competitive Benchmarking (1/5)
Public Trading Comparables (FY 20--)
Company A Company B Company C Company D Company E
Market Capitalization (INR bn) -
Share Price (INR)
EV/EBITDA (x)
EV/Revenue (x)
PE Ratio (04/04/2014)
NUTRACEUTICALS MARKET IN INDIA 2014.PPT

15. 15
Key Ratios of Major Public Companies – Operational Basis (FY 20--) (1/3)
Competitive Benchmarking (2/5)
-20
0
20
40
60
80
x8
x7
Company ECompany B
x4
Company D
x9 x12
x5 x6
x10
x11
%
x1
x2
Company A
x3
Gross Margin Net MarginOperating Margin
• xx
NUTRACEUTICALS MARKET IN INDIA 2014.PPT
SAMPLE

16. 16
Public: Domestic Company – Company A (1/4)
Key People
Products and Services
Company Information Offices and Centres – India
Category Products/Services
Segment Product 1, product 2, product
3,………………….
Others Product 1, product 2, product 3………
Name Designation
Person 1 Designation
Person 2 Designation
Person 3 Designation
Person 4 Designation
Head Office
Corporate Address
Company Address
Tel No. +91-xx- yyyyyyyyy
Fax No. +91-ww-zzzzzzzz
Website www.companyA.com
Year of Incorporation 19--
Ticker Symbol ------
Stock Exchange Exchange Name
NUTRACEUTICALS MARKET IN INDIA 2014.PPT

17. 17
Financial Snapshot Key Ratios
Financial Summary
• The company earned a net profit of INR x4 mn in FY 20--, as
compared to net profit of INR x3 mn in FY 20--
• The company reported total Income of INR y4 mn in FY 20--
registering an increase of x% over FY 20--
• The company earned an operating margin of p% in FY 20--, a
decrease of y percentage points over FY 20--
• The company reported debt to equity ratio of q in FY 20--, an
increase of r% over FY 20--
Financial Summary
Indicators Value
Market Capitalization (INR) z1
Total Enterprise Value (INR) z2
EPS (INR) z3
PE Ratio (Absolute) z4
Profit / Loss
Total Income
20--
d
Profit
INR mn
f
g
h
Total Income
INR mn
a
b
y4
x4
y3
20--
x3
20--
c
y2
x2
20--
y1
x1
Public: Domestic Company – Company A (2/4)
Particulars
y-o-y change
(20-----)
20-- 20-- 20-- 20--
Profitability Ratios
Operating Margin -3.31 7.37% 10.69% 11.63% 14.80%
Net Margin -6.73 4.02% 10.75% 12.08% 7.61%
Profit Before Tax Margin -5.22 6.52% 11.74% 15.66% 11.00%
Return on Equity -7.25 5.51% 12.76% 13.22% 9.02%
Return on Capital Employed -2.22 8.50% 10.73% 12.11% 16.70%
Return on Working Capital -7.92 20.82% 28.74% 28.25% 56.05%
Return on Assets -1.89 6.67% 8.56% 10.77% 14.08%
Return on Fixed Assets -4.90 26.02% 30.92% 33.44% 41.15%
Cost Ratios
Operating costs (% of Sales) 3.47 92.50% 89.03% 87.70% 84.70%
Administration costs (% of
Sales)
5.78 33.11% 27.33% 22.91% 25.64%
Interest costs (% of Sales) -0.24 0.82% 1.06% 1.21% 1.74%
Liquidity Ratios
Current Ratio 0.43% 2.49 2.48 4.42 2.60
Cash Ratio -14.77% 0.53 0.63 1.76 1.09
Leverage Ratios
Debt to Equity Ratio 7.22% 0.32 0.30 0.01 0.02
Debt to Capital Ratio 5.46% 0.24 0.23 0.01 0.02
Interest Coverage Ratio -12.08% 9.10 10.35 10.14 8.78
Efficiency Ratios
Fixed Asset Turnover 23.09% 3.47 2.82 2.72 2.69
Asset Turnover 14.00% 0.89 0.78 0.88 0.92
Current Asset Turnover 6.29% 1.66 1.56 1.78 2.26
Working Capital Turnover 5.98% 2.78 2.62 2.30 3.66
Capital Employed Turnover 14.65% 1.02 0.89 1.02 1.13
NUTRACEUTICALS MARKET IN INDIA 2014.PPT

18. 18
SAMPLE
Key Business Segments Key Geographic Segments
Business Highlights (1/2)
Description News
Overview • xx
Nutraceutical
Products
• yy
Product Launch • zz
Expansion Plans • ww
76% 88% 85% 65%
0%
20%
40%
60%
80%
100%
20--
13%
2%
19%
20--
4% 1%
11%
20--
0% 1%
11%
20--
3%
21%
Segment 4
Segment 3
Segment 2
Segment 1
13%
0%
20%
40%
60%
80%
100%
20--
5%
95%
20--
3%
97%
20--
3%
97%
20--
87%
Country 2Country 1
Public: Domestic Company – Company A (3/4)
NUTRACEUTICALS MARKET IN INDIA 2014.PPT

19. 19
SAMPLE
S W
TO
Public: Domestic Company – Company A (4/4)
•Opportunity 1
•Opportunity 2
•Opportunity 3
•Threat 1
•Threat 2
•Threat 3
•Strength 1
•Strength 2
•Strength 3
•Weakness 1
•Weakness 2
•Weakness 3
NUTRACEUTICALS MARKET IN INDIA 2014.PPT

20. 20NUTRACEUTICALS MARKET IN INDIA 2014.PPT
Private: Foreign Company – Company B (1/5)
Key People
Company Information Offices and Centres – India
Corporate Address
Company Address
Tel No. +91-xx- yyyyyyyyy
Fax No. +91-ww-zzzzzzzz
Website www.companyA.com
Year of Incorporation 20--
Products and Services
Head Office
Category Products/Services
Segment Product 1, product 2, product
3,………………….
Others Product 1, product 2, product 3………
Name Designation
Person 1 Designation
Person 2 Designation
Person 3 Designation
Person 4 Designation

21. 21
Shareholders of the Company as on xx/yy/20-- Ownership Structure
Private: Foreign Company – Company B (2/5)
Name No. of Shares held
Total
x%
Type 1
NUTRACEUTICALS MARKET IN INDIA 2014.PPT

22. 22
Financial Snapshot Key Ratios
Financial Summary
• The company earned a net profit of INR x4 mn in FY 20--, as
compared to net profit of INR x3 mn in FY 20--
• The company reported total Income of INR y4 mn in FY 20--
registering an increase of x% over FY 20--
• The company earned an operating margin of p% in FY 20--, a
decrease of y percentage points over FY 20--
• The company reported debt to equity ratio of q in FY 20--, an
increase of r% over FY 20--
Profit / Loss
Total Income
20--
d
Profit
INR mn
f
g
h
Total Income
INR mn
a
b
y4
x4
y3
20--
x3
20--
c
y2
x2
20--
y1
x1
Particulars
y-o-y change
(20-----)
20-- 20-- 20-- 20--
Profitability Ratios
Operating Margin -3.31 7.37% 10.69% 11.63% 14.80%
Net Margin -6.73 4.02% 10.75% 12.08% 7.61%
Profit Before Tax Margin -5.22 6.52% 11.74% 15.66% 11.00%
Return on Equity -7.25 5.51% 12.76% 13.22% 9.02%
Return on Capital Employed -2.22 8.50% 10.73% 12.11% 16.70%
Return on Working Capital -7.92 20.82% 28.74% 28.25% 56.05%
Return on Assets -1.89 6.67% 8.56% 10.77% 14.08%
Return on Fixed Assets -4.90 26.02% 30.92% 33.44% 41.15%
Cost Ratios
Operating costs (% of Sales) 3.47 92.50% 89.03% 87.70% 84.70%
Administration costs (% of
Sales)
5.78 33.11% 27.33% 22.91% 25.64%
Interest costs (% of Sales) -0.24 0.82% 1.06% 1.21% 1.74%
Liquidity Ratios
Current Ratio 0.43% 2.49 2.48 4.42 2.60
Cash Ratio -14.77% 0.53 0.63 1.76 1.09
Leverage Ratios
Debt to Equity Ratio 7.22% 0.32 0.30 0.01 0.02
Debt to Capital Ratio 5.46% 0.24 0.23 0.01 0.02
Interest Coverage Ratio -12.08% 9.10 10.35 10.14 8.78
Efficiency Ratios
Fixed Asset Turnover 23.09% 3.47 2.82 2.72 2.69
Asset Turnover 14.00% 0.89 0.78 0.88 0.92
Current Asset Turnover 6.29% 1.66 1.56 1.78 2.26
Working Capital Turnover 5.98% 2.78 2.62 2.30 3.66
Capital Employed Turnover 14.65% 1.02 0.89 1.02 1.13
Private: Foreign Company – Company B (3/5)
NUTRACEUTICALS MARKET IN INDIA 2014.PPT

23. 23NUTRACEUTICALS MARKET IN INDIA 2014.PPT
Description News
Overview • xx
Network • yy
Nutraceutical
Products
• zz
Expansion Plans • ww
Business Highlights
Private: Foreign Company – Company B (4/5)
SAMPLE

24. 24
SAMPLE
S W
TO
•Opportunity 1
•Opportunity 2
•Opportunity 3
•Threat 1
•Threat 2
•Threat 3
•Strength 1
•Strength 2
•Strength 3
•Weakness 1
•Weakness 2
•Weakness 3
Private: Foreign Company – Company B (5/5)
NUTRACEUTICALS MARKET IN INDIA 2014.PPT

25. 25NUTRACEUTICALS MARKET IN INDIA 2014.PPT
Strategies that can help players penetrate deeper into the
market
`
• xx
Strategic
Recommendations
• yy
• zz
• ww

26. 26
Thank you for the attention
About Netscribes, Inc.
Netscribes, Inc. is a knowledge-consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of
investment & business research, business & corporate intelligence, content-management services, and knowledge-software services. At its
core lies a true value proposition that draws upon a vast knowledge base. Netscribes, Inc. is a one-stop shop designed to fulfil clients’
profitability and growth objectives.
Nutraceutical Market – India report is part of Netscribes’ Healthcare Series.
For any queries or customized research requirements, contact us at:
Disclaimer: This report is published for general information only. Although high standards have been used in the preparation, “Netscribes” is
not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior
permission is required for guidelines on reproduction.
Follow us on:
Phone: +91 22 4098 7600
E-Mail: info@netscribes.com
NUTRACEUTICALS MARKET IN INDIA 2014.PPT